Study 3 of 12Tesamorelin literatureSemanticScholar2010
Semantic Scholar search for Tesamorelin
Not reported in abstract.
Where it sits
this study against the rest of the tesamorelin corpus1
Preclinical · this one
2
Observational
0
Open-label
7
Randomised
2
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.00). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2010
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Key findings
- Not reported in abstract.
- Not reported in abstract.
- Not reported in abstract.
Limitations
- Not reported in abstract.
- Not reported in abstract.
- Not reported in abstract.
Elsewhere in the Tesamorelin corpus
ATesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH): a clinical trial protocol.BMJ open · 2026HumanAThe effect of growth hormone-releasing hormone on cognition and brain connectivity in adults with cognition ranging from normal to mild cognitive impairment.eNeurologicalSci · 2026 · Not reported in abstract.HumanAEffect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.JAMA · 2014 · n=83 · -34 cm2 mean change in visceral adipose tissue with tesamorelin vs 8 cm2 with placebo; P=0.005.HumanARelationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease.The Journal of clinical endocrinology and metabolism · 2021 · Not reported in abstract.HumanBThe relationship between acromegaly and hepatic steatosis: insights from FibroScan imaging.europepmc · 2026 · CAP scores: 241.8 ± 50.0 dB/m in acromegaly patients, 281.7 ± 61.2 dB/m in metabolically matched controls, p < 0.001.HumanATesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH): a clinical trial protocol.europepmc · 2026Human